Because of its association with T cell activation and transmigration, we hypothesized increased CD99 expression in MS patients, which could be a driver of an overall higher inflammatory state, but we did not find any significant differences between MS patients and healthy individuals in the peripheral blood. The gene discussed is CD99; the disease is myeloid sarcoma.